Flavia Castelino is a Rheumatology/Immunology physician affiliated with Harvard University. OpenAlex indexes 80 publications with 2,461 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St Yawkey 2c
Rheumatology Unit, Mgh,
Boston, MA 02114
Telephone
617-726-7938Registry record last updated 18 Feb 2011.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202531 payments$19,747openpaymentsdata.cms.gov ↗
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20247 payments$14,620openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
50.4%Folate Analog Metabolic Inhibitor22.7%Methotrexate100%Part D≥67 patientsTNF inhibitor19.8%Humira(Cf) Pen70%Enbrel Sureclick23%Humira Pen7%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
24.9%Corticosteroid15.9%Prednisone100%Part D≥57 patientsProton pump inhibitor4.9%Omeprazole73%Pantoprazole Sodium27%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
7.6%Xanthine oxidase inhibitor5.8%Allopurinol100%Part D≥18 patientsNonsteroidal Anti-inflammatory Drug1.8%Diclofenac Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2012–2016 per NIH RePORTER. The latest:
- The Role Of Lysophosphatidic Acid (LPA) And Its Receptor, LPA1 In Scleroderma
Massachusetts General Hospital
FY2016$162,854K08AR062592 - The Role Of Lysophosphatidic Acid (LPA) And Its Receptor, LPA1 In Scleroderma
Massachusetts General Hospital
FY2015$132,570K08AR062592 - The Role Of Lysophosphatidic Acid (LPA) And Its Receptor, LPA1 In Scleroderma
Massachusetts General Hospital
FY2015$1,000K08AR062592
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis
Arthritis Care & Research
2026 - Use of Nintedanib for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States
Annals of the American Thoracic Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Mark Shrime, MD
Harvard University
Thoralf Sundt, MD
Harvard University
Dhaval Kolte, MBBS, PhD
Harvard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”